Carcinoma D002277

Description

A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer."   MeSH

Hierarchy View

Subtype Terms (19)

Adenocarcinoma
1440 drugs (416 approved, 1024 experimental)

Carcinoma, Adenosquamous
54 drugs (39 approved, 15 experimental)

Carcinoma, Basal Cell
80 drugs (54 approved, 26 experimental)

Carcinoma, Basosquamous
2 approved drugs

Carcinoma, Ehrlich Tumor
 

Carcinoma, Giant Cell
2 approved drugs

Carcinoma in Situ
174 drugs (98 approved, 76 experimental)

Carcinoma, Krebs 2
 

Carcinoma, Large Cell
20 drugs (16 approved, 4 experimental)

Carcinoma, Lewis Lung
 

Carcinoma, Ovarian Epithelial
489 drugs (174 approved, 315 experimental)

Carcinoma, Papillary
19 drugs (14 approved, 5 experimental)

Carcinoma, Small Cell
77 drugs (45 approved, 32 experimental)

Carcinoma, Squamous Cell
518 drugs (172 approved, 346 experimental)

Carcinoma, Transitional Cell
234 drugs (101 approved, 133 experimental)

Carcinoma, Verrucous
50 drugs (29 approved, 21 experimental)

Mammary Analogue Secretory Carcinoma
 

Nasopharyngeal Carcinoma
168 drugs (76 approved, 92 experimental)

Thyroid Carcinoma, Anaplastic
34 drugs (23 approved, 11 experimental)


Phase 4 Indicated Drugs (126)

Key: D002277 (63) Subtype (63)

Phase 3 Indicated Drugs (347)

Key: D002277 (193) Subtype (154)

131i-lipiodol

177lu-dota0-tyr3-octreotate

2-fluoropyrimidine

5-hydroxy-tryptamine

64cu-dota-daratumumab

68ga-psma

68ga-rm2

Abagovomab

abexinostat

abt-869

acelarin

acetogenins

acetylcarnitine

aciclovir (zovirax)

ag-120

aglatimagene besadenovec

ags-003

albumin (Human) (Plasbumin)

allovectin

amifostine (ethyol)

amt2003

Andrographis paniculata

ang1005

anlotinib

apalutamide (erleada)

arginine

arsenic trioxide (trisenox)

as04

asparaginase (elspar)

atezolizumab (tecentriq)

atrasentan hydrochloride

autologous bone marrow

autologous dendritic cells

autologous ebv specific cytotoxic t lymphocytes

autologous human tumor-derived hsppc-96

azd-4547

bacampicillin (spectrobid)

bacille calmette-guerin

batabulin sodium

bavituximab

belagenpumatucel-l

bempegaldesleukin

bgj398

bicalutamide (casodex)

bintrafusp alfa

bms-986205

bortezomib (velcade)

brigatinib (alunbrig)

brivanib alaninate

cabazitaxel (jevtana kit)

camrelizumab

carbenicillin (pyopen)

carbogen

carbon dioxide (dry ice)

carvone

cediranib

cemiplimab (libtayo)

cg0070

chlorotrianisene (tace)

choline c11 (choline c-11)

cidofovir (vistide)

cinacalcet (sensipar)

ckd602

clavulanate (Augmentin)

clonidine (catapres)

clopidogrel (plavix)

cm-082

cobalamin

cobimetinib (cotellic)

combretastatin

cpi 613

crizotinib (xalkori)

cs1001

cs1003

cyclophosphamide (cytoxan)

cyclosporine (sandimmune)

cyproviron

cytokine induced killer cells

d961

daclatasvir (daklinza)

dapsone (aczone)

dasabuvir (Exviera)

dcfpyl

degarelix acetate (firmagon)

denosumab (prolia)

dexamethasone

diindolylmethane

lapatinib (tykerb)

l-epigallocatechin

leuprolide (lupron)

levamisole (ergamisol)

levoleucovorin (fusilev)

linsitinib

lobaplatin

long-chain triglyceride

loxo-292

lurbinectedin

medroxyprogesterone (provera)

megestrol (megace)

melatonin

methylene blue (proveblue)

mezlocillin (mezlin)

minocycline (minocin)

mirvetuximab soravtansine

mitogel

mitoxantrone (novantrone)

mitumomab

mk-6482

modotuximab

momelotinib

multikine

muscadine grape skin extract

n-(4-hydroxyphenyl)all-trans retinamide

napabucasin

naptumomab estafenatox

natriumfolinate

nelfinavir (viracept)

nerolidol

nexavar

nicotinamide

nilutamide (nilandron)

nucleotides

nulogyl

ombitasvir (Viekira Pak)

oprelvekin (Neumega)

opt-821

orantinib

oregovomab

osimertinib (tagrisso)

oxybutynin (ditropan)

oxygen

palbociclib (ibrance)

pamiparib

panitumumab (vectibix)

paritaprevir (viekira pak)

pasireotide (signifor)

patent blue v dye

pegylated arginine deiminase

pemigatinib

pemtumomab

perfluorobutane

peripheral blood hematopoietic cell

pertuzumab (perjeta)

pexastimogene devacirepvec

phenoxodiol

pi-88

piperacillin (pipracil)

polyunsaturated fatty acids

polyvalent antigen-klh conjugate vaccine

porfimer (photofrin)

porfiromycin

pralsetinib

pravastatin (pravachol)

probiotic

procaine benzylpenicillin (novocaine)

proxinium

pyridoxine

ramucirumab (cyramza)

recombinant human adenovirus type 5

recombinant human choriogonadotropin alfa (Ovidrel)

Recombinant Human Type-5 Adenovirus

regorafenib (stivarga)

reolysin

retifanlimab

retinoic acid

rice bran

rigosertib

rilotumumab

ritonavir (Norvir)

rogaratinib

romiplostim (nplate)

rrx-001

rucaparib (rubraca)

saracatinib

Phase 2 Indicated Drugs (1013)

Key: D002277 (555) Subtype (458)

105ad7

111in-dota-cg250

111in-idec-159

123i-iodometomidate

125-iodine

131i-psma-1095

13c-pyruvate

177lu-dota-cg250

177lu-psma-r2

18f-2-fluoro-2-deoxy-d-glucose fluorodeoxyglucose

18f-fluciclatide

18f-rgd

2-fluoropropionyl-labeled pegylated dimeric rgd peptide

2x-121

3bp-227

4scar-fra

4scar-psma

68ga-imp-288

68ga-nodaga-rgd

68ganota-anti-her2 vhh1

7-hydroxystaurosporine

90y-dota-tyr3-octreotide

90y-idec-159

90y-re

90y-smt487

99mtc ec20

a166

abc-294640

abemaciclib (verzenio)

abt-510

abt-751

abt-806

abx196

acalabrutinib (calquence)

acetic acid (vosol)

acetylcysteine (mucomyst)

activated cik and cd3-muc1 bispecific antibody

activated lymphocytes

ad5.f35-hgcc-padre

adagloxad simolenin

adavosertib

ad-cea vaccine

adenoviral vector expressing hsv-tk

adenovirus-code muc1 and survivin transfected dendritic cells

adh300004

ad.hifn-beta

adxs11-001

adxs-503

aeg35156

afamelanotide (Scenesse)

afimoxifene

aflibercept (zaltrap)

afuresertib

agatolimod

ags-1c4d4

ak104

ak-104

ak-105

aldoxorubicin

alemtuzumab (campath)

alendronic acid (fosamax)

alisertib

alks 4230

allogeneic dendritic cells

allogeneic hematopoietic stem cells (Hemacord)

allogeneic lymphocytes

allogeneic mononuclear cells

allogeneic natural killer cells

allopurinol (zyloprim)

allostim

allovax

alpelisib (Piqray)

alpha (1,3) galactosyltransferase expressing allogeneic tumor cells

alpha-methyltryptophan

alpha-type-1-polarized dendritic cell

als-008176

alt-801

alt-803

aluminum

alvac(2)-ny-eso-1 (m)/tricom vaccine

alvac-cea-b7.1 vaccine

alvac ny eso-1 vaccine

alvocidib

amd-070

amg-319

amg-337

aminocamptothecin

aminosyn ii

amphinex

amrubicin

anetumab ravtansine

anrotenib

anti-ceaxanti-dtpa bispecific antibody

anti-hcd70 car pbl

anti-kras g12v mtcr

anti-muc1 vaccine

antineoplaston a10

anti-ny eso-1 mtcr pbl

anti-ny eso-1 t-cell receptor pbl

antiprimod

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin)

apatorsen

apitolisib

apl-101

apl-501

apr-246

aprepitant (Emend)

apx005m

aqua

aroplatin

arq 087

arry-614

artesunate

arzoxifene hydrochloride

as1411

ascrinvacumab

asn-002

ast-008

astragalus polysaccharides

atn-161

attenuated live listeria encoding hpv 16 e7 vaccine

atu027

auranofin (ridaura)

autologous cd34+ cells transduced withpsrs11.efs.il2rg.pre

autologous cik cells

autologous dc-vaccines

autologous gp96 vaccination

autologous lymphocytes

autologous mesenchymal stem cells

autologous natural killer cells

autologous pbmcs

autologous rcc tumor derived cells

autologous renal cell vaccine based on dnp modified cells

autologous T cell memory cells

autologous tumor infiltrating lymphocytes

autologous umbilical cord blood

auy922

avb-s6-500

ave-1642

azacitidine (vidaza)

azd1775

azd5069

azd-5672

azd6738

azd9150

b-701

baclofen (lioresal)

bax69

bay383441

bay86-7548

bay94-9392

bazedoxifene (Duavee)

bb-401

bbi503

becatecarin

beetroot juice

belinostat (beleodaq)

bendamustine (treanda)

beractant (survanta)

berberine

berzosertib

beta-lapachone

betamethasone (celestone)

bevacizumab-irdye800cw

bi-2536

bim 23a760

bimiralisib

binimetinib (mektovi)

birinapant

bkt-140

black raspberry

bls_ilb_710c

bls-ilb-e710c

bls_ils_e710c

blu-554

bms 180549

bms-813160

bms-906024

bms-986016

bms-986156

bms-986183

bnc 105p

bosutinib (bosulif)

br55

branched chain amino acids

brinjal

bromelains

bryostatin

buparlisib

bupropion (wellbutrin)

busulfan (myleran)

c11-sodium acetate

cabiralizumab

calcitriol (rocaltrol)

calcium

can04

cap1-6d

cap-232

cap7.1

capmatinib

carboxyamidotriazole

carcinoembryonic antigen peptide 1

carfilzomib (kyprolis)

caricotamide

carmustine (bicnu)

carotenoids

carotuximab

carvedilol (coreg)

catumaxomab

cb-103

cb-839

cc-122

cc-223

cc-486

cct301

ccx872-b

cd24fc

cd8+ t cells

CDP1

cdx-014

cdx-301

cdx-3379

cea car-t cells

cea gene modified t cells

cep-11981

ceralasertib

ceritinib (zykadia)

cetrelimab

cetugex

cf-102

cgi-1842

chidamide

chloroquine

chlorpheniramine

cigb-300

cik cells

cilengitide

cimetidine (tagamet)

cinobufacin

cinobufacini

cixutumumab

ck-101

claudiximab

cll442

clobetasol (dermovate)

colchicine (colbenemid)

compound 2055269

conatumumab

conjugated equine estrogens

copanlisib (aliqopa)

coriolus versicolor

cp-18

cp-547632

cpi-613

cr1447

cranberry

crcl-allovax

crgd-zw800-1

crs-207

cs-2164

cudc-907

curcumin

cv301

cv8102

cvac

cvx-060

cx1106

cx-2009

cyanocobalamin (berocca)

cytolytic t-lymphocytes

cytotoxic t cells

dabrafenib (tafinlar)

dacarbazine (dtic-dome)

dacomitinib (vizimpro)

dactolisib

dalantercept

dalteparin (fragmin)

danggui buxue tang

dasatinib (sprycel)

dc-006 vaccine

dc1-ctl

dcb-bo1202

dc-cik cells

dc ova

dc/rcc fusion vaccine

dcr-myc

dcvac/ovca in parallel

dec-205/ny-eso-1 fusion protein cdx-1401

decitabine (dacogen)

defactinib

demcizumab

dendritic cell activated cytokine-induced killer cell

dendritic cell-precision multiple antigen t cells

dendritic cells

dendritic cell tumor fusion vaccine

dendritic cell vaccine for high risk ovarian cancer patients

denenicokin

denileukin diftitox (ontak)

derazantinib

dianhydrogalactitol

diclofenac (voltaren)

di-dtpa-131i

diethylnorspermine

digoxin (lanoxin)

dihydroartemisinin

dimethylarsinous glutathione

dinitrophenyl

diphenhydramine (benadryl)

dipropyltryptamine

dipyridamole (persantine)

dkn-01

dn24-02

dnazyme targeting ebv-lmp1

dolastatin

dotatoc-90y

doxycycline (vibramycin)

dpx-survivac

duligotuzumab

dutasteride (avodart)

duvelisib (copiktra)

e10a

e39 peptide vaccine

e39 vaccine

e 7070

e7090

echinacea angustifolia

echinomycin

edaravone (radicava)

edp1503

ef5

efalex

efatutazone

eflornithine (ornidyl)

eft508

eftilagimod alpha

egen-001

egfr antisense dna

egfr bats

egf-rp64k

egfrviii peptide

elacytarabine

electrofusion dc vaccine

emactuzumab

emd 1201081

emibetuzumab

emricasan

enadenotucirev

enasidenib (idhifa)

encorafenib (braftovi)

endostatin adenovirus

enfortumab vedotin (Padcev)

enmd 2076

entrectinib (Rozlytrek)

enzastaurin

eo2401

ep-100

epc2407

epha2 peptide

ephb4-hsa fusion protein

epidermal growth factor

epstein-barr virus specific white blood cells

erdafitinib (Balversa)

ery001

esk981

estradiol (progynon depot)

estramustine (emcyt)

et140202 autologous t cell product

etanercept (enbrel)

etaracizumab (abegrin)

etarfolatide

etbx-011

etbx-021

etbx-051

etbx-061

etirinotecan pegol (Onzeald)

etodolac (lodine)

eviendep

exatecan mesylate

f16il2

fam-trastuzumab deruxtecan-nxki (Enhertu)

faza

fbp peptide

ferumoxytol (feraheme)

fgf-5

ficlatuzumab

fimaporfin

finasteride (Proscar)

flotegatide

floxuridine (fudr)

fludarabine (fludara)

fluoromethylcholine (18f)

fluoromisonidazole

fluorothymidine

fluvastatin (lescol)

folate-fluorescein conjugate

foretinib

forrad

fostamatinib

fowlpox-prostate specific antigen vaccine

fralpha peptide

fruquintinib

ft-2102

g1t38

ga 68 dota-neobomb1

ga-68-dota-toc (Ga-68-dota-toc)

gabapentin (neurontin)

gadobenate (multihance)

galeterone

gallium-68-dotatate (netspot)

gallium citrate ga 67

galunisertib

ganciclovir (cytovene)

gastrin 17 vaccine

gatipotuzumab

gb1275

gc1008

gc-1118

gd2 car t cells

gen-009

gen-1

gen1029

gen1046

genistein

gentamicin (garamycin)

gi-4000

gi-6207

gi-6301

gl-0817

glembatumumab vedotin

glizigen

gl-onc1

gm.cd40l.ccl21

gm.cd40l cells

gm.cd40l vaccine

gm-neo and panc 6.03 pcdna-1

gns561

golvatinib

gonadorelin (factrel)

gosspyl acetate

gossypol sodium

gp-100 peptide vaccine

gpc3 car-t cell

gpi-0100

grapiprant

grn163l

grt-c901

grt-r902

gsk2256098

gsk-2636771

gti-2040

guadecitabine

gv 1001

gvax pancreatic cancer vaccine

gx-188e

h3b-6545

hank

hb-201

hbi-8000

hemopoietic stem cell

heparin (liquaemin)

hepatitis b vaccine (recombinant) (recombivax)

her2bi-armed activated t cells

her2/neu peptide

her-2/neu peptide vaccine

herpes simplex thymidine kinase

histamine dihydrochloride

hmpl-453

hpv e6-specific tcr-t cell with anti-pd1 auto-secreted element

hsp70 dna vaccine

hspe7

hu5f9-g4

human papillomavirus 16 monovalent

humax-il8

hydroxychloroquine (plaquenil)

ibi310

icrucumab

idarubicin (idamycin)

idec-159

il13r alpha peptide

il-7

ilixadencel

ima970a

imatinib (gleevec)

imp288

imp4297

imprime pgg

imu-131

in111 monoclonal antibody mn-14

inactivated influenza vaccine

incb054828

incmga00012

incomplete freund's adjuvant

indomethacin (indocin)

indoximod

infliximab (remicade)

iniparib

ino-3100

ino-5401

ino-9012

inodiftagene vixteplasmid

int230-6

interferon alfa-1b

interleukin-12

interleukin-12 dna

intuvax

in vitro-treated peripheral blood stem cell

iodine-124

ioflupane i-123

ipatasertib

ipi-549

iron oxide

iron sucrose (venofer)

irradiated donor lymphocyte

irx-2

isa 101

Isatuximab (Sarclisa)

isis 2503

isis 5132

ispinesib

it-101

ixabepilone (ixempra)

ixazomib (ninlaro)

j65 vaccine

ketoconazole (nizoral)

keyhole limpet hemocyanin

kl-a167

kn046

krt-232

ky1044

labetuzumab govitecan

lactoferrin

ladiratuzumab vedotin

lag-3

lag525

larotrectinib (vitrakvi)

l-dos47

lefitolimod

lenalidomide (revlimid)

lergopenin

l-glutamic acid

lifileucel

linagliptin (tradjenta)

liocyx

liposomal lurtotecan

liposomal t4n5

lipotecan

lirilumab

lithium (lithonate)

litronesib

ljm716

lmb-100

ln-145-s1

load703

lovastatin (mevacor)

lucitanib

lurtotecan

lutetium dotatate lu-177 (Lutathera)

ly2181308

ly2510924

ly-295501

ly-3023414

m6620

macleaya cordata

mage-3.a1 peptide

maltodextrin

manganese chloride

mapatumumab

mart-1 antigen

masct:multiple antigens specific cellular therapy

masitinib

matuzumab

mb-002

mb07133

mbp-426

mcpyv tag-specific polyclonal autologous cd8-positive t cells

mcs110

mebendazole (vermox)

medi0457

medi0562

medi0680

mesna (mesnex)

mesothelin car t cells

metformin (glucophage)

methylprednisolone (medrol)

mg4101

mgd013

mgi-114

mgn1601

mifepristone (mifeprex)

milciclib

mipsagargin

miv-818

Mix vaccine

mk-0646

mk-1454

mk-1775

mln0264

moc31-pe

mocetinostat

modified vaccinia virus ankara vaccine expressing p53

mogamulizumab (poteligeo)

molibresib

monalizumab

monoclonal antibody hmn-14

montanide isa51

motexafin gadolinium

Motixafortide

motolimod

moxr0916

ms-20

msk-2206

muc1 car-t cells

muc1 dendritic cell vaccine

multi-epitope folate receptor alpha peptide vaccine

multivitamins

muromonab cd3 (Orthoclone OKT3)

mva-bn-brachyury

mvt-5873

mycobacterium w vaccine

myoinositol

n803

natural killer cells

navitoclax

nbtxr3

nc318

nc6004

nci-4650

nd-420

necitumumab (portrazza)

nedisertib

nelipepimut-s

neoantigen dna vaccine

nerlynx

nerofe

netazepide

ngr-htnf

niclosamide (nicloside)

nicotine (nicorette)

ningetinib

nintedanib (ofev)

nir178

nk-92

nk cell

nktr-214

nktr-262

norgestrel (Ovral)

nuc-1031

ny-eso-1(c259)t cells

obi-3424

obi-821

oblimersen sodium

obp-301

oc-001

oc-eies

oc-igt cells

ocoxin

octanoic acid

oleclumab

oligo fucoidan

ombrabulin

omega-3 fatty acids (omacor)

omeprazole (prilosec)

omiganan

onapristone

onc201

onc-392

oncolytic measles virus encoding thyroidal sodium iodide symporter

oncoxin-viusid

ondansetron (zofran)

opb-31121

opc-18

opioid growth factor

oprozomib

opt-822

orca-010

ortataxel

orteronel

ose2101

oshadi d

oshadi r

osi-461

osi-7904l

osilodrostat

otl38

ovarian cancer specific cytotoxic lymphocytes

ovax

oxaloacetate

ozanimod

p03277

p53 peptide vaccine

p53-slp

palladium-bacteriopheophorbide

palonosetron (aloxi)

panc 10.05 pcdna-1

pancrelipase (creon)

panobinostat (farydak)

pantoprazole (protonix)

papain

para-toluenesulfonamide

paratyphoid a and b vaccine

paricalcitol (zemplar)

parvovirus h-1

patritumab

patupilone

pbi-05204

pd-0360324

pd-l1 peptide vaccine

pds0101

pegaspargase (oncaspar)

peginterferon beta-1a (Plegridy)

peg-pei-cholesterol lipopolymer-encased il-12 dna plasmid vector gen-1

pegph20

pelitinib

pen-221

pen-866

pentostatin (nipent)

pentoxifylline (trental)

pep503

pepcan

perifosine

pevonedistat

pexidartinib (Turallo)

pf-04136309

pf-04518600

pf-04856884

pf3084014

pf804

phenelzine (nardil)

phenylacetic acid (ucephan)

phenylacetylgluatmine

photochlor

phy906

phytosome

picropodophyllin

pidilizumab

pik-pd-1 cells

pilaralisib

pimasertib

pioglitazone (actos)

piritrexim

pivanex

plerixafor (mozobil)

plevitrexed

plx2853

plx-8394

pngvl4a-sig/e7

polyglutamate camptothecin

poly-iclc

pomalidomide (pomalyst)

ponatinib (iclusig)

poziotinib

pr-104

pralatrexate (folotyn)

precision multiple antigen t cell

prexasertib

pri-724

prl3-zumab

procaine merethoxylline

progenta

progesterone (progestasert)

prolycopene

prostvac-v/tricom

psa:154-163 peptide vaccine

pt-112

pt2385

ptvg-hp plasmid dna vaccine

ptx-9908

pumvc3-higfbp-2

quarfloxin

quercetin

quinacrine

quisinostat

rad001

radium-223 (xofigo)

ralimetinib

raloxifene (evista)

ramosetron

ranitidine (zantac)

rapamycin

rc48-adc

re188-p2045

rebimastat

recombinant adenoviral human p53 gene

recombinant epstein-barr virus vaccine

refametinib

regn4018

relacorilant

relatlimab

resiquimod

resistant starch

resminostat

retinostat

rg-7599

rhil-7-hyfc

ribociclib (kisqali)

rilimogene gamvacirepvec

rimabotulinumtoxinB (Myobloc)

rintatolimod

risperidone (risperdal)

rivaroxaban (xarelto)

riviciclib

ro4929097

ro5137382

ro5217790

ro6874281

rocuronium (zemuron)

romidepsin (istodax)

rosiglitazone

rosuvastatin (crestor)

rovalpituzumab tesirine

rp1

rpi.4610

rubitecan

rutoside

ruxolitinib (jakafi)

rx-0201

sacituzumab govitecan

sagopilone

samital

sapanisertib

saridegib

sasanlimab

savolitinib

saw palmetto

scb01a

sch66336

sct200

sd-101

selicrelumab

selinexor (Xpovio)

selumetinib

sepantronium bromide

seribantumab

sf1126

sgn-15

shr-1316

sig12d loder

silibrin

silmitasertib

siltuximab (sylvant)

simtuzumab

simvastatin (zocor)

sir-spheres

sitravatinib

sivifene

sjg-136

skb264

slc-0111

sn-38

sndx-6352

SNS-301

sodium acetate

sodium cridanimod

sodium dichloroacetate

sodium phenylbutyrate (buphenyl)

sonepcizumab

songyou

sonolisib

sox

soy isoflavones

spartalizumab

squalamine

sr-t100

ss1(dsfv)pe38

sta-4783

staphylococcus aureus vaccine

starch

stp705

sulfatinib

sulforaphane

sulindac (clinoril)

suramin

t-900607

tabelecleucel

tac-101

tadalafil (cialis)

tag-7 gene modified inactivated tumor cells

tak-117

talabostat

taladegib

tamibarotene

tandutinib

tanespimycin

tariquidar

tarloxotinib

tasidotin

tasisulam

tasquinimod

taxoprexin

tazarotene (tazorac)

tazemetostat

tc-210 t cells

tc 99m ec20

tecemotide

tefinostat

telisotuzumab (Teliso-V)

temoporfin

temozolomide (temodar)

tepotinib

tesetaxel

testosterone (delatestryl)

tetanus toxoid

tetrahydrouridine

tetrandrine

tetra-o-methyl nordihydroguaiaretic acid

tew-7197

tezacitabine

tf2

tg4001

th2 rapa cells

thergap-02

thiamine

thiotepa

thioureidobutyronitrile

thymosin alpha-1

thyrotropin (thyropar)

tigatuzumab

tiomolibdate ion

tipelukast

tipiracil (lonsurf)

tisotumab vedotin

titanium silicide

tkm-080301

tlc 388

tlk286

tnp-470

tobramycin (nebcin)

tocilizumab (actemra)

tocotrienol

tosedostat

tpiv100

tpiv200

trastuzumab emtansine (kadcyla)

trc253

triad vaccine

triapine

triciribine

triethylenetetramine (trientine)

trifluridine (viroptic)

trigriluzole

trilostane (modrastane)

trolamine polypeptide oleate condensate (cerumenex)

trovafloxacin (trovan)

trx-818

tucatinib

tucotuzumab celmoleukin

tumor necrosis factor

tumor-pulsed dendritic cells

tumour infiltrating lymphocytes

turmeric

typhoid vaccine

tyrosinase peptide

ucpvax

ugn-102

uprosertib

urelumab

uridine

urokinase-derived peptide

urokinase-derived peptide a6

utomilumab

v3-ova

v3-x vaccine

vaccinia prostate-specific antigen vaccine

vaccinium myrtillus

vactosertib

vadimezan

val201

valaciclovir (Valtrex)

vancomycin (Vancocin)

varlilumab

varlitinib

vatalanib

vb10.16

ve800

veliparib

vemurafenib (zelboraf)

venetoclax (venclexta)

vistusertib

vitamin a

viusid

vk-2019

vm4-037

volociximab

von hippel-lindau peptide vaccine

vorinostat (zolinza)

vosaroxin

VSV-IFNβ-NIS

vx-970

wild-type reovirus

wnt974

wst11

wt1 126-134 peptide

x-82

xl765

xl999

xrp6976

y90 monoclonal antibody mn-14

ykl-40 peptide

young tumor infiltrating lymphocytes

ytttrium-90 microspheres

z-360

z650

zafirlukast (accolate)

zanolimumab

zarnestra

zd6126

zibotentan

zkab001

zn2+

zn-c3

zoptarelin doxorubicin

zw25

α-glu-trp

Phase 1 Indicated Drugs (488)

Key: D002277 (246) Subtype (242)

111in-cp04

131i-tm-601

177lu-psma-617

188re-sss lipiodol

18f fpm

18f-αvβ6-bp

23-valent pneumococcal polysaccharide vaccine (pneumovax-23)

2-fluorofucose

2g-1 tcr retroviral vector-transduced lyn

64cu-dota-eclii

68ga-nodaga-e(c[rgdyk])2

6b11-ocik

89zr-bevacizumab

89zr˗dfo˗regn3504

89zr-mmot0530a

99mtc-etarfolatide

99mtc mip 1404

99mtc mip 1405

ab928

abbv-085

abbv-181

abbv-221

abbv-368

abbv-927

abi-1968

abituzumab

ad5-delta24rgd

ad5.sstr/tk.rgd

ad5-ycd/muttksr39rep-adp

adalimumab (humira)

adct-301

adgmcaix-transduced autologous dendritic cells

adh-1

ad-magea3

adxs-neo

afp464

afp peptides

ags-16m18

ags-16m8f

ags-8m4

alfatide

alm201

alpha-lipoic acid

alpha-tocopheryloxyacetic acid

alvac-hb7.1

alvespimycin

amatuximab

amg 172

amg 211

amg 228

amg 910

anakinra (kineret)

andes-1537

antiangiogenic peptide vaccine therapy

anti cd45 monoclonal antibody

anti-cea designer t cells

anti-macrophage migration inhibitory factor antibody

anti-nf-p2x7

anti-ny eso-1 tcr-transduced t cells

ar-42

arg1-18,19,20

aro-hif2

as1409

asg-5me

asn007

atovaquone (mepron)

atr-101

autologous ad her2 dendritic cells

autologous anti-psca-car-4-1bb/tcrzeta-cd19t-expressing t-lymphocytes

autologous dendritic cells loaded with autologous tumor lysate

autologous genetically modified afpc332 t cells

autologous genetically modified mage a10c796 t cells

autologous hematopoietic cell

autologous monocyte-derived dendritic cells transfected with dna

autologous monocytes

autologous ny-eso-1-specific cd8-positive t lymphocytes

avid100

avmacol

azd-1480

azd4635

azd-8055

azd8186

bay1895344

bay2287411

bcd-100

bcd-135

bemarituzumab

bethanechol (urecholine)

bexarotene (targretin)

bi 754091

bi 754111

bi 905711

biib-022

biomed 101

birabresib

bivalent oral polio vaccine (bopv), type 1 and type 3

bivatuzumab

bivatuzumab mertansine

blu-667

bms-833923

bp1001

bpx-601

bushen-jianpi

bvd-523

calcipotriene (dovonex)

canakinumab (ilaris)

cannabidiol (Epidiolex)

carcinoembryonic antigen-expressing measles virus

cb-1158

cbt-101

cc-115

cd137l-dc-ebv-vax

cd147-car t cells

cd40 ligand

cd8+nkg2d+ akt cell

cdx1307

cea-loaded dendritic cells

cefepime (maxipeme)

cend-1

cep-37250

certolizumab pegol (cimzia)

cesium 131

cgx1321

cibisatamab

ciforadenant

ciml nk

cinobufotalin

cintredekin besudotox

cjm112

clivatuzumab tetraxetan

clostridium butyricum

c-met/pd-l1 car-t cell

colloidal gold-bound tumor necrosis factor

colo-ad1

cosibelimab

cp-870893

cpg dna

cpi-006

cpi-444

cpl304110

crenolanib

crs-100

crx100

ctt1057

cu64-dota b-fab

cue-101

cusatuzumab

cyh33

cyl-02

cytochlor

daratumumab (darzalex)

dc rcc-rna

debio1143

deferoxamine (desferal)

dendritic cell loaded with ofa

dimethane sulfonate

dinaciclib

disulfiram (antabuse)

dky709

dnajb1-prkaca peptide vaccine

dnr.npc-specific t cells

dribbles

ds-2248

dsp-7888

dusigitumab

e7 tcr transduced pbl cells

ebv-lmp-2

ec1456

egf816

EGFR-BATs

emi-137

endoxifen

entolimod

envafolimab

ep-2101

epcam car-t cells

epstein-barr virus cytotoxic t lymphocytes

et1402l1-cart cells

ethinyl estradiol (Estinyl)

ex vivo-expanded her2-specific t cells

f 18 ara-g

falimarev

famotidine (pepcid)

f-arag

fate-nk100

flaxseed

flucytosine (ancobon)

fluorescein

fluoroestradiol

fondaparinux sodium (arixtra)

fowlpox-sargramostim

g1t48

gamma-delta t cells

gc33

gc4419

gelofusin

genetically engineered ny-eso-1-specific t lymphocytes

genetically modified ctls

genolimzumab

gevokizumab

gi heptapeptide

gimatecan

gla-se

glatiramer acetate (copaxone)

glycar t cells

gm-csf plasmid

gpc3 and/or tgfβ targeting car-t cells

gr-md-02

gsk2879552

gsk 525762

gz17-6.02

h2nvac

h3b-6527

hcc antigens-specific cd8+ t lymphocytes

her-2 car-t cells

herv-e tcr transduced cd8+/cd34+ t cells in hlaa* 11:01 positive patients

hf10

hkt288

hla-a02 restricted hig2

hpv16 e7 peptide-pulsed autologous dcs

hpv e6-specific T cells

hpv specific t cells

htert/survivin multi-peptide vaccine

human fecal microbiota

human prostate-specific membrane antigen plasmid dna vaccine

hyperacute-renal cancer vaccine

iacs-010759

idelalisib (zydelig)

ifx-hu2.0

il-18

il-4(38-37)-pe38kdel

ima201

imab027

imc-cs4

imexon

imgatuzumab

in111-dota-girentuximab-irdye800cw

in111 monoclonal antibody hu3s193

inalimarev

inbrx-105

inbrx-106

inbrx-109

incagn02385

incagn02390

incb050465

incb062079

incb099280

incb099318

incyclinide

ing-1

ino-1400

interferon beta-1b (betaseron)

interleukin-10

interleukin-15

iopamidol (Isovue)

ipafricept

irgd

itacitinib

jab-3312

jiu-wei-zhen-xiao

khk2455

khk2866

ksp-qrh-e3-irdye800

ktn3379

kyn-175

lcar-c182a

lcl-161

leq-506

lgk974

licochalcone

liver nk cell

lmb-9

lmp2 antigen-specific tcr t cells

lmp-specific cytotoxic t-lymphocytes

l-nmma

losartan (cozaar)

ltx-315

luteolin

ly-2584702

ly-3039478

ly3143921

ly3214996

ly3300054

ly3381916

ly3435151

m4344

Maackia amurensis seed

mabel ctls

mage-a3 peptide

mdc3/8-kras vaccine

mdx-1203

mdx-1411

me-344

meclizine (antivert)

medi-565

medi5752

medi7247

merestinib

mesenchymal stromal cells-derived exosomes with kras g12d sirna

metenkefalin

methoxyamine

mg1-magea3

mgd007

mgd009

midostaurin (rydapt)

minnelide

minretumomab

mixed bacterial vaccine

mkc1106

mm-141

mm-151

mm-310

morab-066

motexafin lutetium

mouse prostate-specific membrane antigen plasmid dna vaccine

mov-gamma chimeric receptor gene

moxifloxacin (avelox)

mrna-2752

mrx0518

mrx34

msc-infbeta

mtl-cebpa

mva-ebna1/lmp2 vaccine

mva-fcu1

mv-nis

neo-201

neo-pv-01

neovax

nis793

nkg2d car-t cell

nkg2dl-targetting chimeric antigen receptor-grafted gamma delta t cell

norethisterone (Norlutin)

nortriptyline (aventyl)

ny-eso-1

ny-eso-1 olp4

ny-eso-1 protein

nzv930

obinutuzumab (gazyva)

oc-dc

onalespib

onartuzumab

ont-10

opb-111077

opb-51602

ovarian cancer peptides

oxycodone (oxycontin)

oxytocin (syntocinon)

p16-093

pancreatic tumor peptide-pulsed dendritic cells

panda-vac

panvac

pd-1 knockout t cells

pek fusion protein vaccine

pentamidine (pentam)

pertscan-99m

pf-06940434

pf-07062119

(pg13-a(f/k-f-sgsg-t2a-b (opt) (2g-1 tcr) retroviral vector-transduced lymphocyte

pneumococcal 13-valent conjugate vaccine (prevnar 13)

pngvl3-hicd vaccine

pngvl4acrte6e7l2

pramlintide (symlin)

prgn-3005

prilocaine (citanest)

prn1371

proflavine sulfate

prolactin g129r

prostate specific membrane antigen

prt543

ptc596

ptp-01

pv701

qrh-882260

qs-21

raltegravir (isentress)

ras peptide cancer vaccine

rav12

rebastinib

recombinant fowlpox-cea(6d)/tricom vaccine

recombinant vesicular stomatitis virus-expressing interferon-beta

resveratrol

retinoid 9cuab30

rg-7600

rhenium

ricolinostat

ridaforolimus

rimiducid

rindopepimut (Rintega)

rituximab (rituxan)

ro5323441

ro6870810

ro7070179

rose bengal disodium

rsifn-co

rta 744

rxdx-105

s-adenosyl methionine

sativex

sb 11285

sbp-101

sc002

sc-003

sch 209702

sch 721015

sea-cd40

semi-allogenic human fibroblast (mrc-5) transfected with dna

seneca valley virus

sephb4-hsa

sevacizumab

sgn-75

sgn-cd228a

sgn-cd47m

sgn-cd70a

shr-1701

sildenafil (viagra)

sinnabidol

sirna-transfected peripheral blood mononuclear cells apn401

sl-279252

s-methionine

snx-5422

so-c101

sodium selenium oxide

sofituzumab vedotin

solamargine

sor-c13

sovateltide

sparc147609

spl-108

stk1-ligand

stm 434

stro-002

survivin-peptide double loaded dendritic cells

svn53-67/m57-klh peptide vaccine

taest16001

tak-441

tak-659

talactoferrin alpha

tauroline

tbi 302

t-cells

tcr redirected t cells

tegar t cells

tetmyb

tg02

tg4050

tgdcc-e1a

tilsotolimod

tk99un

tmtp1

tno155

tofacitinib (xeljanz)

tp-0903

tp3805

tpst-1120

transgenic lymphocyte immunization vaccine

trk-950

tti-101

tti-621

u3-1784

ucb-nk cells

v934-ep

v935

valganciclovir (valcyte)

valspodar

vax014

vcn-01

vsv-hifnbeta-nis

vvdd-cdsr

vx15/2503

w_ova1 vaccine

xanthaurine

xl092

xl281

xl888

xmab20717

xmab22841

xmab23104

y90 conjugated chimeric g250

y90 dota anti-cea monoclonal antibody m5a

y90 edotreotide

y90 glass microspheres

y90 monoclonal antibody hu3s193

yang yin fu zheng

yang yin fu zheng jie du

ye-neo-001

yttrium-90

zsp1241

zsp1602

Other Experimental Indicated Drugs (81)

Key: D002277 (47) Subtype (34)


Organization Involved with Phase 4 Indications (127)

Key: D002277 (60) Subtype (67)

Organization Involved with Phase 3 Indications (394)

Key: D002277 (217) Subtype (177)

Aarhus University

Abbott

AbbVie

Academic and Community Cancer Research United

Accord Research

Activate Immunotherapy

Active Biotech AB

Advanced Accelerator Applications

Advanz Pharma

AEterna Zentaris

Agenus Inc.

Agios Pharmaceuticals, Inc.

AGO Germany

All India Institute of Medical Sciences

American College of Radiology

Amgen

AnewPharma

Angiochem Inc

Anyang Regional Hospital

Arbeitsgemeinschaft medikamentoese Tumortherapie

Argos Therapeutics

Ariad Pharmaceuticals

Assistance Publique - Hôpitaux de Paris

Associació per a la Recerca Oncologica, Spain

Association of Urogenital Oncology (AUO)

Associazione Volontari Pazienti Oncologici

Astellas

Auron Healthcare GmbH

AVEO Pharmaceuticals

Avid Bioservices

Azienda Sanitaria Rummo, Benevento, Division of Medical Oncology

Azienda USL Nord Ovest

Barretos Cancer Hospital

BeiGene

Beijing Shenogen Biomedical Co., Ltd

Belgian Group of Digestive Oncology

Biofrontera Bioscience GmbH

BioNumerik Pharmaceuticals, Inc.

Biotest Pharmaceuticals

BioVex

Blokhin's Russian Cancer Research Center

Blueprint Medicines Corporation

Boehringer Ingelheim

Boston Biomedical

Brown University

BTG

Cairo University

Canadian Cancer Trials Group

Cancer and Leukemia Group B (CALGB)

CancerCare Manitoba

Cancer Hospital of Guizhou Province

Cancer Research UK

Cancer Trials Ireland

Cedars-Sinai Medical Center

Celltrion

CEL-SCI

Celsion

Center Eugene Marquis

Central European Cooperative Oncology Group

Centre Catherine de Sienne - Nantes

Centre Georges Francois Leclerc

Centre hospitalier de Mulhouse

Centre Hospitalier de Saint-Brieuc

Centre Hospitalier Intercommunal Creteil

Centre Jean Perrin

Centre Leon Berard

Charité-Universitätsmedizin Berlin

Chinese Society of Lung Cancer

Chinese University of Hong Kong

Chonnam National University

Clinical Research Organization, Dhaka, Bangladesh

Clinica Universidad de Navarra

Clinique Pasteur

Clovis Oncology

Cold Genesys, Inc.

Collaborative Group for Adrenocortical Carcinoma Treatment

Cornell University

Croix-Rousse Hospital, Lyon

CStone Pharmaceuticals

Curie Institute

Daiichi Sankyo

Danish Head and Neck Cancer Group

Delcath Systems

Dendreon

Dutch Society of Physicians for Pulmonology and Tuberculosis

Eastern Cooperative Oncology Group

EBMT Solid Tumors Working Party

ECOG-ACRIN Cancer Research Group

Eleison Pharmaceuticals

Eli Lilly

Endocyte

Endo Pharmaceuticals

Ente Ospedaliero Ospedali Galliera

EpicentRx, Inc.

Erasmus University Rotterdam

ERYtech Pharma

Eurofarma Laboratorios S.A.

European Lung Cancer Working Party

European Network for Gynaecological Oncological Trial

European Organisation for Research and Treatment of Cancer

Evangelischen Diakoniekrankenhaus

Federal University of Rio Grande do Sul

Federation Francophone de Cancerologie Digestive

FeRx

Fondazione Michelangelo

Foresee Pharmaceuticals Co., Ltd.

François Rabelais University

French National Agency for Research on AIDS and Viral Hepatitis

Fujian Medical University

Fundación Althaia Manresa

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Genentech

Genmab

Genzyme

German Breast Group Forschungs GmbH

Ghent University

Gilead Sciences

Government of China

Government of Colombia

Government of Japan

Government of Poland

Government of Singapore

Government of Taiwan

Graceway

Gradalis, Inc.

Greater Baltimore Medical Center

Green Cross Corporation

Groupe Hospitalier Paris Saint Joseph

Groupe Oncologie Radiotherapie Tete et Cou

Grupo de Investigación Clínica en Oncología Radioterapia

Grupo Español de Investigación en Cáncer de Ovario

Gruppo Oncologico del Nord-Ovest

Gruppo Oncologico Italiano di Ricerca Clinica

GTx

Guangxi Medical University

Guangzhou Double Bioproducts Co., Ltd

Guangzhou Medical University

Guizhou Medical University

Gynecological Oncology Center South (GOCZ)

Gynecologic Oncology Group

Gynecologic Oncology Trial & Investigation Consortium

Halozyme Therapeutics

Harbin Medical University

Hasselt University

Henan Medical University

Hengrui Therapeutics, Inc.

Henry Ford Health System

Hong Kong Nasopharyngeal Cancer Study Group Limited

Hôpital Bretonneau

Hospital Avicenne

Hospital general Universitario de Ciudad Real

Hospital Regional Universitario Carlos Haya

Hospital Universitario Lucus Augusti

Huai'an First People's Hospital

Imclone

immatics Biotechnologies GmbH

Immunitor LLC

ImmunogenX

Impact Therapeutics, Inc.

Incyte

Indira Gandhi Medical College

Innovent Biologics (Suzhou) Co. Ltd.

Inovio Pharmaceuticals

Institut Bergonié

Institut Català d'Oncologia

Institut de Cancérologie de Lorraine

Institut de Cancerologie de l'Ouest Paul Papin

Institut Gustave Roussy

Instituto do Cancer do Estado de São Paulo

Institut Paoli-Calmettes

Institut Sainte Catherine

InterMune

International Breast Cancer Study Group

Introgen Therapeutics

Ipsen

Ivy Life Sciences, Co., Ltd

Japan Clinical Oncology Group

Japanese Gynecologic Oncology Group

Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd

Jilin University

Jinan University

Johns Hopkins University

Johnson and Johnson

J. W. Goethe University

Karolinska Institute

Katholieke Universiteit Leuven

Klinikum Vest - Knappschaftskrankenhaus, Recklinghausen

Kuwait Cancer Control Center

Kyowa Hakko Kirin

Leo Pharma

Lexicon Pharmaceuticals

Light Sciences Oncology

L'Institut Mutualiste Montsouris-Paris

LSK BioPartners Inc.

Ludwig Maximilians University

MacroGenics

Mahidol University

Mateon Therapeutics

McMaster University

Meda

Medical Enterprises Europe B.V.

Medical Research Council

Medical University of Graz

Medical University of Lublin

Medical University of Vienna

Medigen Biotechnology Corporation

MEI Pharma

Menarini Group

Merck KGaA

Merck Serono

Miami Cancer Institute

Moorgreen Hospital, Southampton

Morphotek

Nanning Second People's Hospital

NantCell, Inc.

National Cancer Center, Korea

National Cancer Institute (NCI)

National Cheng Kung University

Nationale Centrum für Tumorerkrankungen

National Hepatology & Tropical Medicine Research Institute

National Institute of Allergy and Infectious Diseases (NIAID)

National Taiwan University

Navidea Biopharmaceuticals

Nektar Therapeutics

Netherlands Cancer Institute

New York Presbyterian Hospital

Nihon University

Nordic Society for Gynaecologic Oncology

North Central Cancer Treatment Group

North Eastern Germany Society of Gynaecologic Oncology

Northwestern University

Novelion Therapeutics

NovoCure Ltd.

NRG Oncology

NSABP Foundation

Oasmia Pharmaceutical AB

Oncocare Sonnenhof-Klinik Engeriedspital

Oncolytics Biotech

Onconova Therapeutics, Inc.

Onxeo

Optimal Health Research

Oregon Health and Science University

Otsuka

Oxford BioMedica

Pancreatic Cancer Action Network

Parc Tauli Hospital

Paris Descartes University

Pariser Dermatology Specialists

PellePharm, Inc.

Pharmacyclics

PharmaMar

Photocure

Pierre Fabre

Polaris Group

Princess Al-Johara Al-Ibrahim Cancer Research Center

Progenics

Progen Pharmaceuticals

QED Therapeutics, Inc.

Qingdao Central Hospital

Radboud University

Radiation Therapy Oncology Group

Rafael Pharmaceuticals Inc.

Regeneron

Rocky Mountain Cancer Centers

Royal Marsden Hospital NHS Trust

Saarland University

Sanofi

Scottsdale Healthcare

Second Military Medical University

SFJ Pharmaceuticals, Inc.

Shandong Provincial Cancer Hospital

Shandong Provincial Hospital

Shanghai Henlius Biotech

Shanghai Junshi Bioscience Co.,Ltd.

Shanghai University

Shanghai University of Traditional Chinese Medicine

Shanghai Zerun Biotechnology Co.,Ltd

Shantou University

Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Sichuan University

SillaJen, Inc.

Singapore General Hospital

Sinocelltech Ltd.

Sino-Swed Pharmaceutical Corporation

Sirtex Medical

Sky Ridge Medical Center

Soligenix

Southern Medical University

Southwest Oncology Group

Sponsor GmbH

Stanford University

St. James's Hospital, Dublin

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Swami Rama Cancer Hospital and Research Institute

Swiss Go Trial Group

Swiss Group for Clinical Cancer Research

Symphogen A/S

SynCore Biotechnology

Synta Pharmaceuticals Corp.

Taian Cancer Hospital

Taichung Veterans General Hospital

Taiwan Cooperative Oncology Group

Takeda

Tata Memorial Hospital

TC Biopharm

Technical University of Munich

Telesta Therapeutics

Tesaro

Tessa Therapeutics

The Christie NHS Foundation Trust

The First People's Hospital of Changzhou

The Second People's Hospital of GuangDong Province

The Second People's Hospital of Sichuan

The University of Hong Kong

Tianjin Medical University

Tongji University

Trans Tasman Radiation Oncology Group

Tribhuvan University

Tsinghua University

TTY Biopharm

Tufts University

Tularik

Umea University

UNICANCER

United States Army

United States Navy

Unither Pharmaceuticals

Universidad Autonoma de Barcelona

Universidad Autonoma de Madrid

Universidad Complutense de Madrid

Universidad de Cordoba

Universita' Cattolica del Sacro Cuore

University Hospital Birmingham NHS Foundation Trust

University of Alberta

University of Antwerp

University of Basel

University of Birmingham

University of Brescia

University of Burgundy

University of California, Los Angeles

University of California, San Francisco

University of Copenhagen

University of Coruna

University of Edinburgh

University of Erlangen-Nuremberg

University of Freiburg

University of Genoa

University of Glasgow

University of Hamburg

University of Heidelberg

University of Indonesia

University of Kansas

University of Kinshasa

University of Lille

University of Limoges

University of Liverpool

University of London

University of Lorraine

University of Louisville

University of Malaga

University of Montpellier

University of Naples Frederico II

University of Nice Sophia Antipolis

University of Oklahoma

University of Ottawa

University of Pittsburgh

University of Poitiers

University of Regensburg

University of Reims

University of Rennes

University of Rochester

University of Salamanca

University of Seville

University of Southern California

University of South Florida

University of Turin

University of Warwick

University of Western Ontario

UroGen Pharma

Vancouver Coastal Health

VBL

Vical

Viventia Biotech Inc.

Wayne State University

Wilex

Women's Cancer Care Associates, LLC

Wuhan University

Xiamen University

Xinxiang Medical University

Xynomic Pharmaceuticals, Inc.

Yale University

Yamagata University

Zai Lab Pty. Ltd.

Zhengzhou University

Organization Involved with Phase 2 Indications (802)

Key: D002277 (457) Subtype (345)

4SC AG

A2 Healthcare Taiwan Corporation

Abivax S.A.

AB Science

Acceleron Pharma, Inc.

Accenture

Acerta Pharma

Acorn Cardiovascular, Inc.

Adaptimmune

Aduro BioTech

Advaxis, Inc.

Advenchen Laboratories, LLC

Advent Health

Aegera Therapeutics

Aeon Therapeutics (Shanghai) Co., Ltd.

Aga Khan University

Agennix

Agensys, Inc.

Aichi Medical University

AIDS Malignancy Consortium

Aix-University of Marseille

Ajou University

Akeso Pharmaceuticals, Inc.

Alberta Health Services, Calgary

Alkermes

Allina Health

Alphamab Co., Ltd.

AltaRex

Altor Bioscience

American University of Beirut

Ameriderm Research

Anchiano Therapeutics

Ångstrom Pharmaceuticals

Annecy Interregional Hospital

Antengene Corporation

Antisoma Research

Apollomics, Inc.

Aprea Therapeutics AB

Aptose Biosciences Inc.

Aqualis

Aravive Biologics

Arbutus Biopharma Corporation

Arizona State University

Aronex Pharmaceuticals

ArQule

Array BioPharma

Arrys Therapeutics

Aslan Pharmaceuticals

Asociación de Oncología Médica del Hospital de Cruces

Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials

Associacio Per la Recerca Oncológica

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (ARTIC)

Astex Pharmaceuticals, Inc.

Atara Biotherapeutics

Atossa Genetics, Inc.

Attenuon

Auckland District Health Board

Augusta University

Austin Health

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Australia New Zealand Gynaecological Oncology Group

Austrian Breast and Colorectal Cancer Group

AVAX Technologies

Axcentua Pharmaceuticals AB

Axelar AB

Ayala Pharmaceuticals, Inc,

Baptist Health

Barts & The London NHS Trust

Barwon Health

Basilea Pharmaceutica

Basque Country University

Baxalta

BCG Oncology, PC

Beijing Huanxing Cancer Hospital

Beijing Konruns Pharmaceutical Co., Ltd.

Benitec Ltd

BerGenBio ASA

Berg, LLC

Besins Healthcare

Bhagwan Mahaveer Jain Hospital

Bharat Hospital

Big Ten Cancer Research Consortium

Billings Clinic

BIND Therapeutics

Bio-Cancer Treatment International Limited

Biogen

BioLeaders Corporation

BioLineRx, Ltd.

Biothera

BioXcel Therapeutics Inc

Blood Transfusion Centre of Slovenia

Boston University

Bracco

British Columbia Cancer Agency

Burzynski Research Institute

Cadila Healthcare

Caladrius Biosciences

California Cancer Center

Calithera Biosciences

Callisto Pharmaceuticals

Cancer Biotherapy Research Group

Cancer Immunotherapy Trials Network

Cancer Research and Biostatistics Clinical Trials Consortium

Cancer Treatment Centers of America

Candel Therapeutics

Can-Fite BioPharma

Cantargia AB

Cardiff University

Carilion Clinic

Cascadian Therapeutics Inc.

CASI Pharmaceuticals, Inc.

Catalysis SL

Cathay General Hospital

Catholic University of Sacred Heart, Rome

Cato Research

CbsBioscience

CellAct Pharma GmbH

Celldex Therapeutics

Cellectar, Inc

Cellestia Biotech AG

Centocor

Central European Society for Anticancer Drug Research (CESAR)

Central India Cancer Research Institute, Nagpur

Centre Hospitalier La Source, Orleans

Centre Hospitalier of Chartres

Centre Paul Strauss

Centro di Riferimento Oncologico - Aviano

Centro Oncológico de Galicia

Cha Medical University

Changhai Hospital

Chao Family Comprehensive Cancer Center

Charles University

Cheil General Hospital & Women's Healthcare Center

Chiles Cancer Center

China Medical University

Chinese Anti-Cancer Association

Chipscreen Biosciences, Ltd.

Chiron

Choithram Hospital and Research Centre

Chong Kun Dang Pharmaceutical

CHR Annecy

Christian Medical College, Vellore, India

Chuan An Biotechnology Co., Ltd.

CHU Besançon

CHU Henri Mondor

CHU Jean Verdier

CHU Morvan

Chung-Ang University

City of Hope National Medical Center

Cleveland BioLabs

Clinique de l'Alma

Clinuvel Pharmaceuticals Limited

CM&D Pharma

CNAO National Center of Oncological Hadrontherapy

Coastal Connecticut Research, LLC

CoImmune

Columbia University

Commissariat A L'energie Atomique

Conatus Pharmaceuticals

Corcept Therapeutics

Corporacion Parc Tauli

Cristal Therapeutics

Criterium, Inc.

CSM Medical University, Lucknow

CTI BioPharma

Cure&Sure Biotech Co., LTD

CureTech Ltd

Curie Manavata Cancer Center, Nashik, India

Cutanea Life Sciences, Inc.

Cylene Pharmaceuticals

CytomX Therapeutics

Cytran

CytRx

Dartmouth University

Dayton Oncology

Deenanath Mangeshkar Hospital & Research Centre

DelMar Pharmaceuticals, Inc.

Department of Radiation Oncology

DFB Pharma

Dicerna Pharmaceuticals, Inc.

Dong-A University

Dynavax Technologies Corporation

Eanm Research Ltd

Eastchester Center for Cancer Care

East Tallinn Central Hospital

Effector Therapeutics

EGEN, Inc.

Egyptian Foundation for Cancer Research

Egyptian Society of Liver Cancer

Eiger BioPharmaceuticals

Emek Medical Center

Emory University

Enterome

Epizyme, Inc.

Erimos Pharmaceuticals

Esperance Pharmaceuticals Inc

Essentia Health

Europejskie Centrum Zdrowia Otwock

Evelo Biosciences

Exalenz Bioscience LTD.

ExcellaBio LLC

Exicure, Inc.

Facet Biotech

Far Eastern Memorial Hospital

Fennec Pharma

First People's Hospital of Foshan

First People's Hospital of Hangzhou

Fondazione del Piemonte per l'Oncologia

Fondazione GISCAD

Food and Drug Administration

Forma Therapeutics, Inc.

Fortress Biotech

Free University of Amsterdam

Free University of Brussels

Fundación de investigación HM

Fundacion Instituto Valenciano de Oncologia

G1 Therapeutics, Inc.

Gabrail Cancer Center

Gachon University

Ganymed Pharmaceuticals AG

Garden State Cancer Center

G&E Herbal Biotechnology Co., LTD

Genelux

General Electric

General Oncology, Inc.

Genexine, Inc.

Genocea Biosciences, Inc.

Genoscience Pharma

Genta

Georgetown University

George Washington University

Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH

GKNM Hospital, Coimbatore, India

Gliknik Inc.

Global OB/GYN Centers of Florida

Glycotope GmbH

Gongwin Biopharm Co., Ltd.

Gossamer Bio Inc.

Gottfried Wilhelm Leibniz Universität Hannover

Government Medical College, Aurangabad, India

Government of Finland

Government of Malaysia

Government of Russia

Government of Ukraine

Greater Cincinnati OB/GYN, Inc.

Griffith University

Gritstone Oncology, Inc.

Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)

Groupe Hospitalier Diaconesses Croix Saint Simon

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Grupo Espanol de Tumores Neuroendocrinos (GETNE)

Grupo Espanol Multidisciplinario del Cancer Digestivo

Grupo Gallego de Investigaciones Oncologicas

Gruppo Italiano Carcinoma Renale

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Guangdong Province Association Study of Thoracic Oncology

Guilin University

Guiyang Medical University

GWT-TUD GmbH

Gynecologic Oncology Associates

H3 Biomedicine Inc.

Hammersmith Medicines Research

Hannover Medical School

Harrington Cancer Center

HealthCare Global Enterprise Ltd.

HealthPartners Institute

Hebrew University

Helix BioPharma Corporation

Hellenic Cooperative Oncology Group

Hellenic Oncology Research Group

Henry M. Jackson Foundation for the Advancement of Military Medicine

Herbert Irving Comprehensive Cancer Center

Hestia Duran i Reynals

Hill Country OB/GYN

Hi-Q Marine Biotech International, Ltd.

Hoag Memorial Hospital Presbyterian

HonorHealth Research Institute

Hookipa Biotech

Hoosier Cancer Research Network

Hope Cancer Institute, Inc.

Hope Research Institute, LLC

Hôpital Européen Georges-Pompidou

HOPITAL LARREY - TOULOUSE

Hôpital Saint Antoine - PARIS

Hospital A.C. Camargo

Hospital Auxilio Mutuo

Hospital de Manises

Hospital de Mataró

Hospital de Sagunto

Hospital General Universitario Morales Meseguer

Hospital Infanta Sofia

Hospital La Paz

Hospital Son Espases

Hospital Son Llatzer

Hospital Universitario Carlos Haya

Hospital Universitario Central de Asturias

Hospital Universitario Fundación Alcorcón

Hospital Universitari Son Dureta

Hospital Virgen Blanca (León)

Human Genome Sciences

Humanitas University

Humanity & Health Research Centre

Hutchison MediPharma

HUYA Bioscience International

Icahn School of Medicine at Mount Sinai

ICO Hospital Durans i Reynals

Idera

Ignyta, Inc.

IGO Medical Group of San Diego

Immune System Key Ltd

Immunicum AB

Immunomedics

ImmunoVaccine Technologies, Inc.

Immunovative Therapies

Immutep S.A.

Imperial College London

Imugene Limited

Infinity Pharmaceuticals, Inc.

Inhibitor Therapeutics

Innate Pharma

Innovation Pharmaceuticals

Inova Health System

Inspyr Therapeutics, Inc.

Institute for Developmental Cancer Therapeutics

Institute of Post Graduate Medical Education & Research

Institut Mutualiste Montsouris

Instituto de Medicina Integral Professor Fernando Figueira

Instituto Europeo de Oncologia

Intensity Therapeutics

Interbalkan Hospital

Interessenverband zur Qualitätssicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland e.

Intergroupe Francophone de Cancerologie Thoracique

International Group of Endovascular Oncology

Ioannina University Hospital

Iovance

Iowa Methodist Medical Center

IRX Therapeutics

ISA Pharmaceuticals

Istituto Clinico Humanitas - Rozzano (MI), Italy

Istituto di Candiolo

Istituto Nazionale per lo Studio e la Cura dei Tumori

Istituto Oncologico Veneto

Istituto Oncologico Veneto IRCCS

Italian Trial in Medical Oncology

James Graham Brown Cancer Center

Janssen Pharmaceutica NV

Japan Clinical Cancer Research Organization

Japan Liver Oncology Group

Jaslok Hospital and Research Centre, Mumbai, India

Jennerex Inc.

Jersey Shore University Medical Center

Jiangmen Central Hospital

Jiangsu Cancer Institute & Hospital

Johannes Gutenburg University

Julius-Maximilians University

Kaiser Franz Josef Hospital

Kansai Hepatobiliary Oncology Group (KHBO)

Kartos Therapeutics, Inc.

Karyopharm Therapeutics Inc

Kasturba Medical College

Keimyung University

Kevelt AS

K-Group Beta

Kharkov Academy of Postgraduate Education

KhonKaen University

Kindai University

King Faisal Specialist Hospital

King Faisal University

Kirax

Kliniken Nordoberpfalz AG Klinikum Weiden Medizinische Kliniken I

Klinik Hirslanden, Zurich

Klus Pharma Inc.

Konkuk University

Korean Association for the Study of Targeted Therapy

Korean South West Oncology Group

Korean Urological Oncology Society

Krankenhaus der Barmherzigen Schwestern Linz

Kunming Medical University

Kura Oncology, Inc.

KwanDong University

Kymab Limited

Laboratorio Elea S.A.C.I.F. y A.

LanZhou University

Latin American Cooperative Oncology Group

Laval University

Leap Therapeutics, Inc.

Lee's Pharmaceutical

Leiden University

LifeBridge Health

Ligand Pharmaceuticals

Lion TCR Pte. Ltd.

Lithuanian University of Health Sciences

Lokon Pharma AB

Loma Linda University

Louisiana State University

Lourdes Hospital

Lousiana Health Sciences Center - Shreveport

Loxo Oncology

Lpath, Inc.

Ludwig Institute for Cancer Research

Lund University

LungenClinic Grosshansdorf

Lyndhurst Gynecologic Associates

Mackay Medical College

Mansoura University

Marche Polytechnic University

Marin Cancer Care

Martin Luther University

Mary Crowley Cancer Center

McGill University

Mebiopharm Co., Ltd

MedicalLogic

Medical University of South Carolina

MediGene

MedImmune

Medivir

Medizinische Hochschule Hannover

MedPacto, Inc.

MedSIR

Meenakshi Ammal Dental College and Hospital

MegaPro Biomedical Co. Ltd.

Melanoma and Skin Cancer Trials Limited

Melanoma Institute Australia

Memorial Health University Medical Center

Memorial Sloan-Kettering Cancer Center

Mercy Medical Center

Mereo BioPharma

Merrimack Pharmaceuticals

Methodist Cancer Center, Houston, Texas

Microbio Co Ltd

Mid-Atlantic Gynecologic Oncology & Pelvic Surgical Associates

Mid-Atlantic Oncology Program

Milad Hospital

Millennium Pharmaceuticals

Mirati Therapeutics Inc.

Mithra Pharmaceuticals

MizMedi Hospital

Molecular Insight Pharmaceuticals

MolMed S.p.A.

Mologen AG

Monofeiya university

Morristown Memorial Hospital

Mount Sinai Hospital, Canada

Mount Vernon Clinical Research, LLC

Mucpharm Pty Ltd

Muljibhai Patel Urological Hospital

Nang Kuang Pharmaceutical Co., Ltd.

Nanjing University

Nanobiotix

NanoCarrier Co., Ltd.

NanOlogy, LLC

NantWorks

National Academy of Medical Sciences of Ukraine

National Baromedical Services

National Center for Research Resources (NCRR)

Nationales Centrum fur Tumorerkrankungen

National Heart, Lung, and Blood Institute (NHLBI)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institutes of Health (NIH)

National OncoVenture

National Science and Technology Development Agency, Thailand

National University of Singapore

National Yang-Ming University

NeoImmuneTech, Inc.

Neovii Biotech

Netherlands Working Group on Immunotherapy of Oncology

Newcastle University

Newish Technology (Beijing) Co.,Ltd.

NewLink Genetics Inc

New Mexico Cancer Care Alliance

NewVac LLC

NextCure, Inc.

Nooshin Hashemi-Sadraei

Northeast Ohio Medical University

Northern California Research Corp

Northern Institute for Cancer Research Newcastle

North Estonia Medical Centre Foundation

Northwell Health

Norwegian University of Science and Technology

Novo Nordisk

N.R.R. Hospital

Nucana

OB/GYN Specialists of the Palm Beaches

OBI Pharma, Inc

Ocellaris Pharma, Inc.

Ochsner Health System

Oddzial Chemioterapii Krakow

Oddzial Kliniczny Kliniki Onkologii

Oddzial Onkologii Klinicznej im L Rydygiera

Odessa National Medical University

Office of R. Garn Mabey, MD

Ohio State University

OHSU Knight Cancer Institute

OncoGenex Technologies

OncoImmune, Inc.

Oncology Venture

Oncolys BioPharma Inc

OncoNano Medicine, Inc.

OncoSec Medical Incorporated

Oncotech

On Target Laboratories, LLC

Onyvax

Orca Therapeutics B.V.

Oryx GmbH & Co. KG

Osaka University

Osakidetza

Oshadi Drug Administration

OSI Pharmaceuticals

Ospedale Sacro Cuore

Our Lady of Mercy Cancer Center

Pakistan Army

Pancreatic Cancer Research Team

Paracelsus Medical University

Parirenyatwa Hospital

PCI Biotech AS

PDS Biotechnology Corp.

Peking University First Hospital

Peloton Therapeutics, Inc.

Pennsylvania State University

People's Hospital of Leshan

Peplin

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Peter MacCallum Cancer Centre

PharmaEngine

Pharmexa A/S

Philippine General Hospital

Philipps University of Marburg

Philogen S.p.A.

Phoenix Biotechnology, Inc

Phoenix Molecular Imaging

Phosplatin Therapeutics

Physician Care Clinical Research LLC

PhytoCeutica

PhytoHealth Corporation

PIQUR Therapeutics AG

Piramal

Planned Parenthood

Plexxikon

Point Therapeutics

Postgraduate Institute of Medical Education and Research

PrECOG, LLC.

Premiere Oncology

Prescient Therapeutics, Ltd.

Prince of Songkla University

Prisma Health

Privo Technologies

Proacta, Incorporated

Providence Health & Services

PsiOxus Therapeutics Ltd

Pusan National University Hospital

Qingdao University

Radio Isotope Therapy of America

RadioMedix

Rainier Therapeutics

Rajavithi Hospital, Bangkok

Ramón González Coro Hospital

Rampart Health, L.L.C.

Ratchavithi Hospital

RedHill Biopharma

Regional Cancer Centre, Trivandram

Regionalny Szpital Specjalistyczny Latawiec

Region Skane

Region Syddanmark

RemeGen

Replimune Inc.

Repos Pharma AB

Rexahn Pharmaceuticals, Inc.

Robin Black OGNP, Costa Mesa California

Rongjie Tao

Rouen Normandy University

Royal Liverpool & Broadgreen University Hospitals NHS Truts

RTOG Foundation

Ruhr University Bochum

Russian Academy of Medical Sciences

Rutgers University

RWTH Aachen University

Saint Francis Memorial Hospital

Salient Pharmaceuticals Incorporated

Samyang Biopharmaceuticals Corporation

San Antonio Military Medical Center

Sanford Health

Sarcoma Oncology Research Center, LLC

SciClone Pharmaceuticals

Scottish Clinical Trials Research Unit

SCRI Development Innovations

Scripps

Seattle Genetics

Senhwa Biosciences, Inc.

Sensei Pharmaceuticals, Inc.

Seth Gordhandas Sunderdas Medical College

Shaheed Beheshti Medical University

Shanghai GeneChem Co., Ltd.

Shanghai Gynecologic Oncology Group

Shanghai Zhangjiang Biotechnology Limited Company

Shantou University Medical College

Shenzhen BinDeBio Ltd.

Shenzhen Geno-Immune Medical Institute

Shenzhen Hornetcorn Bio-technology Company, LTD

Shenzhen SiBiono GeneTech Co.,Ltd

Shijiazhuang Pharma Group (CSPC)

Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

Silence Therapeutics GmbH

Silenseed Ltd

Siller Medical T/A Central Brisbane Dermatology

Sinclair Dermatology Pty Ltd

Singapore Clinical Research Institute

Sinobioway Cell Therapy Co., Ltd.

Siriraj Hospital

Sirna Therapeutics

Situs Cancer Research Center

SmithKline Beecham

Soonchunhyang University

South Carolina Oncology Associates

Southderm Pty Ltd

Southeastern Gynecologic Oncology

Southern China Urology Cancer Consortium

Southern Illinois University

South Plains Oncology Consortium

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

Spanish Oncology Genito-Urinary Group

Spectrum Pharmaceuticals

Spirig Pharma Ltd.

SP Medical College, Bikaner

SRH Wald-Klinikum Gera GmbH

Stamford Pharmaceuticals

State University of New York

State University of New York, Buffalo

State University of New York, Syracuse

Steba Biotech S.A.

Stemcentrx

St. Joseph's Hospital and Medical Center - Phoenix, Arizona

St. Jude Children's Hospital

St. Louis University

Sunesis Pharmaceuticals

Sunshine Lake Pharma Co., Ltd.

Suzhou Kintor Pharmaceutical Inc,

Swedish Cancer Institute

Symphony Capital

Syndax Pharmaceuticals

SYZ Cell Therapy Co..

Taipei Medical University

TaiRx, Inc.

Taiwan Liposome Company

Taizhou Hospital of Zhejiang Province

Tapimmune Inc.

Tarveda Therapeutics

TCM Biotech International Corp.

TCR2 Therapeutics

Technical University of Dresden

Technion University

Teclison Ltd.

Tel Aviv University

Telormedix SA

Temple University

TesoRx Pharma, LLC

TGen Drug Development

Thallion Pharmaceuticals

The Angeles Clinic

The Cleveland Clinic

The European Uro-Oncology Group

The First People's Hospital of Hangzhou

The Jewish General Hospital, Montreal QC, Canada

The National Cancer Center

The Parker Institute

The Queen's Medical Center

Theradex

The Royal Bournemouth Hospital

The University of Texas, Dallas

The University of Texas Health Science Center, Houston

The Wistar Institute

Thomas Jefferson University

Threshold Pharmaceuticals

Titan Pharmaceuticals

Tiziana Life Sciences, PLC

Tokyo Women's Medical University

Tracon Pharmaceuticals Inc.

Transgene

Translational Oncology Research International

Translational Research Informatics Center, Kobe, Hyogo, Japan

Translational Research in Oncology

Trial Form Support S.L.

Trinity College Dublin

Tuen Mun Hospital, Hong Kong

Tulane University

Tzu Chi University

Universidad Carlos III Madrid

University Alicante

University Hospital Hradec Kralove

University of Adelaide

University of Alabama

University of Amsterdam

University of Angers

University of Ankara

University of Arizona

University of Attiko

University of Bergen

University of Bologna

University of Bristol

University of British Columbia

University of Caen-Normandie

University of Calgary

University of California, Berkeley

University of California, Davis

University of California, Irvine

University of Campinas

University of Cantabria

University of Cincinnati

University of Cologne

University of Colorado

University of Colorado, Denver

University of Crete

University of Duesseldorf

University of Duisburg-Essen

University of Florence

University of Franche-Comté

University of Grenoble

University of Groningen

University of Haifa

University of Illinois at Chicago

University of Iowa

University of Jena

University of Kentucky

University of Lausanne

University of Leeds

University of Leicester

University of Leipzig

University of Malaya

University of Manchester

University of Manitoba

University of Maryland

University of Massachusetts

University of Medicine and Dentistry of New Jersey

University of Melbourne

University of Miami

University of Minnesota

University of Montreal

University of Nantes

University of Nebraska

University of New Mexico

University of New South Wales

University of Nottingham

University of Oslo

University of Padova

University of Quebec

University of Queensland

University of Salzburg

University of Saskatchewan

University of South Carolina

University of Southern Denmark

University of Tennessee

University of Texas, Galveston

University of Texas, San Antonio

University of Tokyo

University of Turku

University of Ulm

University of Utah

University of Valencia

University of Vermont

University of Verona

University of Versailles

University of Virginia

University of Western Australia

University of Wisconsin

University of Zaragoza

University Putra Malaysia

Urocare Hospital

Urological Institute of Northeastern New York

US Oncology

Utrecht University

Vaccibody AS

ValiRx

Vedanta Biosciences, Inc.

VentiRx Pharmaceuticals Inc.

Veracity Clinical Research

Verastem, Inc.

Vicus Therapeutics

Virginia Commonwealth University

Virginia Mason Medical Center

Visions Clinical Research

Vita-Salute University of Milano. Italy

V M Medical College & Safdarjang Hospital

Wakayama Medical University

Ward Veterans General Hospital, Taipei

Warwick Medical School

Washington University in St. Louis

Wenzhou Medical University

West German Study Group

West Virginia University

White Plains Hospital

Windy Hill Medical, Inc.

WiSP GmbH

X4 Pharmaceuticals

Xuzhou Medical University

Yakult Honsha Co., LTD

Yeshiva University

Yiviva Inc.

Zeria Pharmaceutical

Ziopharm

Zollernalbklinikum Balingen

Zymeworks Inc.

ZymoGenetics

Organization Involved with Phase 1 Indications (181)

Key: D002277 (91) Subtype (90)